Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests better ways to replace teeth right after extraction

NCT ID NCT05106855

Symptom relief Sponsor: University of Santiago de Compostela Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 60 adults who needed a single tooth replaced right after extraction. Researchers compared two types of implant surfaces and whether adding low-level laser therapy helped. The goal was to see which approach gave the best implant stability and least bone loss over three months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2022

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients satisfying all inclusion criteria and none of the exclusion criteria will be informed verbally and in writing about the study and signed the informed consent form. * The implant area is free of infection * Patients without systemic pathology or medical and general contraindications that are absolute contraindications for surgical procedures; * Adults who agree to take part in the study and signed the informed consent form. * Smokers of less than 5 cigarettes/day. * Not to be completely edentulous. * Need for extraction of at least one tooth. * Post-extraction bone area (fresh alveolus). * Patients with sufficient bone height to obtain primary stability for implant installation (2 mm longer than the largest root). * Edentulous areas with sufficient mesial-distal, buccolingual and interocclusal space for the placement of an anatomical restoration with a prosthetic space of at least 5 mm. Exclusion Criteria: * Immunosuppressed. * Smokers of more than 5 cigarettes/day. * Bleeding rate greater than 30 %. * Presence of active or uncontrolled periodontal disease; * Patients with less than 2 mm of keratinised gingiva. * Implants with primary stability with ISQ \< 50 * When this is not possible, assume a security margin to the inferior dental nerve of at least 1 mm. * Previus history of local radiotherapy in the head and neck region.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dental implant are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

tooth agenesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dental implant Tooth absence Tooth extraction

Contacts and locations

Locations

  • Universidad de Santiago de Compostela

    Santiago de Compostela, A Coruña, 15785, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.